Flowchart of the study participants. by Subeen Kim (11714313)

Subjects:

Characteristics of study participants in women according to frailty groups. by Subeen Kim (11714313)

Subjects:

Percentage of macronutrient intake relative to the acceptable macronutrient distribution range (AMDR) by frailty groups. by Subeen Kim (11714313)

Subjects:

Basic characteristics of the study participants by gender. by Subeen Kim (11714313)

Subjects:

Population density in the Durham–Chapel Hill MSA. by Zahra Al Hamdani (22190008)

“…For every person increase in household size a decrease there was a decrease in the AWM of fruit and vegetable markets and food banks by 40%. …”

Effect of O-ag modifying glycosyltransferases on complement activation and <i>Salmonella</i> interactions with human serum. by Fermin E. Guerra (6084545)

“…Statistical analysis was performed by one-way ANOVA on 3–4 biological replicates, with P values in red indicating statistical significance with P < 0.05. Column bars represent the means, with error bars displaying standard deviation. …”

O-ag length and composition impacts complement activation by <i>Salmonella</i> nontyphoidal and enteric fever serovars. by Fermin E. Guerra (6084545)

<i>S</i>. Paratyphi A has deficient L O-ag production due to R98C mutation in WzzB. by Fermin E. Guerra (6084545)

Reduction of L O-ag production and antigenic shift to O2-antigen in by Fermin E. Guerra (6084545)

“…Statistical analysis was performed by one-way ANOVA on 3–5 biological replicates, with P values in red indicating statistical significance with P < 0.05. Column bars represent the means, with error bars showing standard deviation. …”

The contribution of O-ag length and the Vi capsule to serum resistance is serovar dependent. by Fermin E. Guerra (6084545)

Changes in connectivity of the mPFC among responders and non-responders. by Karel Joineau (21799908)

Subjects:

Data supporting this article. by Karel Joineau (21799908)

Subjects:

CONSORT diagram showing the flow of participants through each stage of the DOREPAR randomized trial for the main outcome (change of VAS). by Karel Joineau (21799908)

Subjects:

Demographic and clinical data at baseline. by Karel Joineau (21799908)

Subjects:

Changes in clinical variables. by Karel Joineau (21799908)

Subjects:

Change of functional connectivity in the SMN after intervention. by Karel Joineau (21799908)

Subjects:

Design of the protocol. by Karel Joineau (21799908)

Subjects:

Schema of the reflexology circuit and the stimulated reflex zones. a. by Karel Joineau (21799908)

Subjects:

Chemical properties of the soil. by Dominika Radzikowska-Kujawska (14439076)

Subjects:

Levels of the second-order research factor - combinations of fertilization, preparation and forecrop. by Dominika Radzikowska-Kujawska (14439076)

Subjects: